Loraz and Teriparatide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Teriparatide (teriparatide). Common drug interactions include colitis microscopic among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Teriparatide. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,695 Loraz users. Check the latest studies of Loraz.

What is Teriparatide?

Teriparatide has active ingredients of teriparatide. eHealthMe is studying from 1,936 Teriparatide users. Check the latest studies of Teriparatide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

23 people who take Loraz and Teriparatide together, and have interactions are studied.

Loraz and Teriparatide drug interactions.

What are the common drug interactions of Loraz and Teriparatide, by gender? *:

female:

Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Peripheral swelling
Diarrhoea
Asthenia (weakness)
Loss of consciousness
Axillary pain
Blood pressure decreased
Dizziness
Groin pain

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)

What are the common drug interactions of Loraz and Teriparatide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)

60+:

Neck pain
Spinal fracture (fracture in one of vertebrae)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Loss of consciousness
Peripheral swelling
Acne (skin problems that cause pimples)
Constipation
Decreased appetite
Dry mouth

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 17 people, 73.91%
Pain: 6 people, 26.09%
High Blood Pressure: 6 people, 26.09%
Sleep Disorder: 5 people, 21.74%
Anaemia (lack of blood): 4 people, 17.39%
Peripheral Swelling: 3 people, 13.04%
Osteomyelitis (infection of bone): 3 people, 13.04%
Insomnia (sleeplessness): 3 people, 13.04%
Fatigue (feeling of tiredness): 3 people, 13.04%
Depression: 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Teriparatide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously